Next-Generation Sequencing in Translational Sarcoma Research: Biological Insights and Emerging Directions
Alessandro De Vita, Sara Violani, Giacomo Miserocchi, Elena Xerxa, Jürgen Bajorath, Silvia Vanni · 2026
Read Next-Generation Sequencing in Translational Sarcoma Research: Biological Insights and Emerging Directions by Alessandro De Vita, Sara Violani, Giacomo Miserocchi, Elena Xerxa, Jürgen Bajorath, Silvia Vanni (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13585967.txt.
Description
Alessandro De Vita and co-authors reviewed this 2026 state of gene sequencing in sarcoma research. Sarcomas are rare, varied cancers where microscope work alone often cannot pin the type. Fast sequencing now finds the fusions, mutations, and copy changes that define subtypes and sometimes point to drugs. The review maps where the technology genuinely helps.
Sequencing has widened detection of both common and rare changes, including druggable rearrangements. Yet its clinical value depends on the subtype, sample quality, and expert interpretation at reference centers. Older tests still complement it. The authors urge care in drawing the line between research findings and bedside decisions, presenting sequencing as powerful but context-bound rather than a universal answer.
Catalog record
| CREATOR | Alessandro De Vita, Sara Violani, Giacomo Miserocchi, Elena Xerxa, Jürgen Bajorath, Silvia Vanni |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |